设为首页 加入收藏

TOP

JANUVIA(sitagliptin)Tablets (二十八)
2017-06-02 09:24:28 来源: 作者: 【 】 浏览:13021次 评论:0
L - 100 MG TABLET BOTTLE LABEL
NDC 0006-0277-31
Januvia®
(sitagliptin) tablets
100 mg
Dispense the accompanying Medication
Guide to each patient.
Each tablet contains 128.5 mg
sitagliptin phosphate, equivalent
to 100 mg sitagliptin.
Rx only
30 Tablets
PRINCIPAL DISPLAY PANEL - 100 mg Tablet Bottle Label
CLOSE
INGREDIENTS AND APPEARANCE
JANUVIA
sitagliptin tablet, film coated
PRODUCT INFORMATION
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0006-0221
Route of Administration ORAL
ACTIVE INGREDIENT/ACTIVE MOIETY
Ingredient Name Basis of Strength Strength
SITAGLIPTIN PHOSPHATE (UNII: TS63EW8X6F) (SITAGLIPTIN - UNII:QFP0P1DV7Z) SITAGLIPTIN 25 mg
INACTIVE INGREDIENTS
Ingredient Name Strength
ANHYDROUS DIBASIC CALCIUM PHOSPHATE (UNII: L11K75P92J) 
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) 
MAGNESIUM STEARATE (UNII: 70097M6I30) 
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) 
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) 
POLYVINYL ALCOHOL, UNSPECIFIED (UNII: 532B59J990) 
FERRIC OXIDE RED (UNII: 1K09F3G675) 
SODIUM STEARYL FUMARATE (UNII: 7CV7WJK4UI) 
talc (UNII: 7SEV7J4R1U) 
titanium dioxide (UNII: 15FIX9V2JP) 
FERRIC OXIDE YELLOW (UNII: EX438O2MRT) 
PRODUCT CHARACTERISTICS
Color PINK (pink) Score no score
Shape ROUND (round) Size 6mm
Flavor  Imprint Code 221
Contains    
PACKAGING
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:0006-0221-28 100 in 1 CARTON 10/16/2006 
1 NDC:0006-0221-01 1 in 1 BLISTER PACK; Type 0: Not a Combination Product  
2 NDC:0006-0221-31 30 in 1 BOTTLE; Type 0: Not a Combination Product 10/16/2006 
3 NDC:0006-0221-54 90 in 1 BOTTLE; Type 0: Not a Combination Product 10/16/2006 
MARKETING INFORMATION
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021995 10/16/2006 
JANUVIA
sitagliptin tablet, film coated
PRODUCT INFORMATION
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0006-0112
Route of Administration ORAL
ACTIVE INGREDIENT/ACTIVE MOIETY
Ingredient Name Basis of Strength Strength
SITAGLIPTIN PHOSPHATE (UNII: TS63EW8X6F) (SITAGLIPTIN - UNII:QFP0P1DV7Z) SITAGLIPTIN 50 mg
INACTIVE INGREDIENTS
Ingredient Name Strength
ANHYDROUS DIBASIC CALCIUM PHOSPHATE (UNII: L11K75P92J) 
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) 
magnesium stearate (UNII: 70097M6I30) 
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) 
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) 
POLYVINYL ALCOHOL, UNSPECIFIED (UNII: 532B59J990) 
FERRIC OXIDE RED (UNII: 1K09F3G675) 
SODIUM STEARYL FUMARATE (UNII: 7CV7WJK4UI) 
talc (UNII: 7SEV7J4R1U) 
titanium dioxide (UNII: 15FIX9V2JP) 
FERRIC OXIDE YELLOW (UNII: EX438O2MRT) 
PRODUCT CHARACT
以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 25 26 27 28 29 30 下一页 尾页 28/30/30
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇CARNITOR(levocarnitine solutio.. 下一篇LENVIMA(lenvatinib ) capsules

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位